You just read:

ImmunoPrecise Announces Artificial Intelligence Collaboration with EVQLV to Accelerate Vaccine and Antibody Discovery for SARS-CoV-2 Coronavirus

News provided by

ImmunoPrecise Antibodies Ltd.

Mar 02, 2020, 07:00 ET